26.01.2012Celgene to Acquire Avila Therapeutics

Oral Btk inhibitor AVL-292 offers promising potential for treatment of B-cell diseases

Press Release
25.01.2012CN Creative Raises Series A Funding to Develop First Medically Approved Electronic Inhaler Nicotine Replacement Therapy for Smoking Cessation

CNC Combining Its Broad Expertise in Smoking Cessation and Electronic Cigarette Technology to Offer Smokers New Medical Options to Reduce Harm and Help Them Quit

Press Release
20.01.2012Advent Life Sciences Invests in Acutus Medical and Acutus Medical Expands Senior Management Team

Funds and team growth for developing a breakthrough medical system for mapping of atrial fibrillation

Press Release
20.01.2012Avila Announces FDA Allowance of Partner Clovis Oncology’s IND Application

Avila Announces FDA Allowance of Partner Clovis Oncology’s IND Application for CO-1686, an Oral EGFR Mutant-Selective Inhibitor - Triggers $4 Million Milestone Payment to Avila

Press Release
19.01.2012Advent Life Sciences Fund I welcomes additional investor

Advent Life Sciences is pleased to welcome the SNCI as an investor in Advent Life Sciences Fund I (ALSF I).  This now brings ALSF I to a final close of just under £100m.

Press Release
04.01.2012Cornerstone Therapeutics Acquires Cardiokine

Cornerstone acquires worldwide rights to investigational therapy for hyponatremia

Press Release
30.12.2011Amsterdam Molecular Therapeutics Announces 2.5 Million Equity Raise

Press Release
18.11.2011FDA approves Erwinaze to treat a form of leukemia

Press Release
18.11.2011EUSA Pharma Announces FDA Approval Of Orphan Drug ERWINAZE™ For Treatment Of Acute Lymphoblastic Leukemia

Press Release
18.11.2011Biocartis completes EUR 71 million (USD 100 million) Series C Fund Raising

Press Release